Health & Biotech Dimerix enters deal to advance trial into treatment for diabetic kidney disease June 7, 2022 Special Report: Dimerix will work with a key Australian diabetic organisation to start a trial on patients with diabetic kidney disease,… ASX Health Stocks: Orthocell reports positive results from nerves reconstruction trial June 7, 2022 ASX health stocks Orthocell says final data read-out of all patients in its Remplir nerve reconstruction trial produced encouraging results. Nanollose to launch Lee Mathews designed garment at Copenhagen global fashion summit June 7, 2022 Special Report: Nanollose will launch a Lee Mathews designed garment made from its eco-friendly Nullarbor lyocell fibre at a leading… Could Aussie cannabinoid companies help solve a global opioid crisis? June 7, 2022 Governments globally are working to reduce the opioid crisis and some ASX cannabinoid companies might have a solution to the… MGC Pharma results provides real hope for Alzheimer’s sufferers June 7, 2022 Special Report: This could be a big win for dementia sufferers, as Aussie-listed biopharma MGC Pharmaceuticals (ASX:MXC) says its latest… ASX Health Stocks: Clarity Pharma gets the go-ahead from US FDA June 6, 2022 ASX biotech Clarity Pharma has announced the approval of its Investigational New Drug (IND) application by the US FDA. Dr Boreham’s Crucible: Will AstraZeneca cash put Starpharma on a rocket back to all-time highs? June 6, 2022 Starpharma has a chunky $300m valuation that looks reasonable considering AstraZeneca is likely to spend $US100m on trials. Weed Week: Sydney Uni says it’s okay to CBD ‘n drive, and cannabis-infused drinks on the rise June 6, 2022 Boston Beer Co launches cannabis iced tea in Canada and University of Sydney says using CBD and driving is fine. Primed for growth: Audeara increases sales channels by 20% by partnering with optometry giant Specsavers June 3, 2022 Special Report: Hearing Health MedTech signs reseller agreement with Specsavers ASX Health Stocks: Healius tracks guidance, wants to focus on pathology and imaging June 3, 2022 Healius says its Q3 Imaging business is slightly ahead of the May guidance, while its Pathology business is ahead of… Next» « Previous